Cannabix Addresses Challenges with Marijuana Testing in the Workplace

大麻应对工作场所大麻测试的挑战

2021-09-14 04:00:10 CFN Media Group

本文共1714个字,阅读需5分钟

Marijuana legalization is on the rise across the United States. While decriminalization is a noble cause, there are many unintended consequences that the government and private sector struggle to manage. One of the most significant challenges is detecting when someone is under the influence of marijuana. Cannabix Technologies Inc. (CSE: BLO) (OTC: BLOZF) is an innovative company actively developing solutions to address this growing problem. There’s no doubt that marijuana use causes cognitive impairment. The adverse effects on attention, memory, and learning can last for days or weeks after the acute effects of “getting high” wear off. While low productivity is a concern for businesses, workplace safety is far more significant with life-or-death implications. Quest Diagnostics, one of the largest drug testing laboratories in the country, recently reported that 4.4 percent of all U.S. workers tested positive for marijuana in 2020. Even worse, 2.2 percent of workers in sensitive industries—like truck driving, pilots, or nuclear power plant workers—tested positive for marijuana. Commonly used urine drug tests cannot determine if individuals are under the influence at the test time, post-accident data suggests that marijuana may play a role in incidents that prompted a drug test. Pre-employment positivity was just 3.7 percent compared to post-accident positivity of 6.4 percent, pointing strongly toward an impact. Quest Diagnostics also found that marijuana use was on the rise in states where the drug has been legalized for recreational use. With a growing number of states falling under that umbrella, employers need to find ways to discourage on-the-job marijuana use to prevent accidents and create a better and more productive workplace. Most marijuana tests do not discern the recency of marijuana consumption and have virtually no correlation to impairment. The need for real-time tests is evident in industries like long-haul trucking. Everyone agrees that truck drivers should never drive under the influence of marijuana, but a new federal clearinghouse and new regulations allowing hair follicle testing have gone too far. These laws could prevent truckers from using recreational marijuana during their own time. Since the clearinghouse went into effect, the industry has already lost nearly 50,000 drivers. Long detection window makes urine tests less useful. Source: Cannabix Technologies Inc. Fortunately, new technologies could open the door to real-time tests. In particular, breath analysis has the potential to detect recent marijuana use. Aerosol particles in exhaled breath are formed from respiratory tract lining fluid that only contains THC for a relatively short period of time (one to three hours), aligning with the peak impairment window. In addition to more accurate readings, breath analysis is non-invasive and non-intrusive, leading to fewer privacy issues. Furthermore, the inexpensive tests don’t require any nurses or technicians, and they can be completed at the point of care rather than sent to a third-party lab. It’s a far better solution than intrusive and expensive urine or blood tests. Cannabix Technologies Inc. (CSE: BLO) (OTC: BLOZF) is quickly developing cannabis breathalyzer technologies that would be appropriate for work place and other settings. In addition to securing patents on its unique approaches, the company’s advanced prototypes are already in beta testing in real world situations. THC Breath Analyzer prototype. Source: Cannabix Technologies Inc. With a growing need among employers and law enforcement, the company could see a lot of growth if it successfully launches a product into the market. Marijuana use has become a growing problem in the workplace. Unfortunately, most conventional marijuana testing methods like oral fluid or urine testing do not correlate well with peak impairment and can show detection of THC after several hours or days after use. Recreational cannabis users who are not “high” could experience a false positive, leading to unfair consequences. Fortunately, new technologies aim to improve accuracy and fairness. Cannabix Technologies Inc. (CSE: BLO) (OTC: BLOZF) is developing THC breath analysis tools that could provide point-of-care solutions that detect marijuana use within a short period of time after consumption. The result is a solution that law enforcement and workplace officials could use to ensure safety and compliance. For more information, visit the company’s website. Disclaimer The above article is sponsored content. CannabisFN.com and CFN Media, have been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: http://www.cannabisfn.com/legal-disclaimer/ This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
大麻合法化在美国各地呈上升趋势。虽然非刑罪化是一项崇高的事业,但有许多意想不到的后果是政府和私营部门努力管理的。最重要的挑战之一是检测某人何时受到大麻的影响。Cannabix Technologies Inc.(CSE:BLO)(OTC:BLOZF)是一家创新型公司,积极开发解决方案来解决这一日益严重的问题。 毫无疑问,吸食大麻会导致认知障碍。对注意力、记忆力和学习的不利影响在“兴奋”的急性影响消失后可能会持续几天或几周。虽然生产率低下是企业的一个问题,但工作场所的安全远比生死攸关的问题重要得多。 该国最大的药物检测实验室之一Quest Diagnostics最近报告称,2020年,4.4%的美国工人大麻检测呈阳性。更糟糕的是,2.2%的敏感行业工人--如卡车司机、飞行员或核电站工人--大麻检测呈阳性。 常用的尿液药物测试不能确定个人在测试时是否受到影响,事故后数据表明,大麻可能在引发药物测试的事件中发挥作用。就业前的积极性仅为3.7%,而事故后的积极性为6.4%,这强烈表明了影响。 Quest诊断公司还发现,在大麻被合法化用于娱乐的州,大麻的使用正在增加。随着越来越多的州落入这一保护伞之下,雇主需要找到阻止在职大麻使用的方法,以防止事故发生,并创造一个更好、更有生产力的工作场所。 大多数大麻测试不能识别大麻消费的最新情况,几乎与损伤无关。 在长途卡车运输等行业,对实时测试的需求是显而易见的。每个人都同意卡车司机永远不应该在大麻的影响下开车,但一个新的联邦信息交换所和允许毛囊测试的新法规已经走得太远了。这些法律可以防止卡车司机在自己的时间内使用娱乐大麻。自清算所生效以来,该行业已经失去了近5万名司机。 较长的检测窗口使尿液检测不太有用。资料来源:Cannabix Technologies公司。 幸运的是,新技术可以为实时测试打开大门。特别是,呼吸分析有可能检测最近的大麻使用情况。呼出气中的气溶胶颗粒是由呼吸道衬里液形成的,该液在相对较短的时间内(1至3小时)只含有四氢大麻酚,与峰值损伤窗口对齐。 除了更准确的读数,呼吸分析是非侵入性和非侵入性的,导致更少的隐私问题。此外,这种廉价的测试不需要任何护士或技术人员,它们可以在护理点完成,而不是送到第三方实验室。这是一个比侵入性和昂贵的尿液或血液测试好得多的解决方案。 Cannabix Technologies Inc.(CSE:BLO)(OTC:BLOZF)正在迅速开发适用于工作场所和其他环境的大麻酒精分析仪技术。除了在其独特的方法上获得专利之外,该公司的先进原型已经在现实世界的情况下进行了beta测试。 THC呼吸分析仪原型。资料来源:Cannabix Technologies公司。 随着雇主和执法部门日益增长的需求,如果公司成功地向市场推出一款产品,它可能会看到很大的增长。 使用大麻已成为工作场所日益严重的问题。不幸的是,大多数常规的大麻测试方法,如口服液或尿液测试,与峰值损伤没有很好的相关性,可以在使用后几个小时或几天内显示THC的检测。不“高”的娱乐性大麻使用者可能会出现假阳性,导致不公平的后果。幸运的是,新技术旨在提高准确性和公平性。 Cannabix Technologies Inc.(CSE:BLO)(OTC:BLOZF)正在开发四氢大麻酚呼吸分析工具,该工具可以提供护理点解决方案,在吸食大麻后的短时间内检测大麻的使用。其结果是执法部门和工作场所官员可以用来确保安全和合规的解决方案。 欲了解更多信息,请访问公司网站。 免责声明 以上文章为赞助内容。cannabisfn.com和CFN Media被雇来提高认识。请按以下链接查看我们概述赔偿的完整披露:http://www.cannabisfn.com/legal-disclaimer/ 本文由CFN Enterprises Inc.(OTCQB:CNFN)发表,该公司是CFN Media的所有者和运营商,CFN Media是行业领先的机构和数字金融媒体网络,致力于新兴的CBD和合法大麻行业。请致电+1(833)420-CNFN了解更多信息。

以上中文文本为机器翻译,存在不同程度偏差和错误;偶尔因源网页结构局限,内容无法一次完整呈现。请理解并参考原站原文阅读。

阅读原文